Donahue Kevin Michael

Donahue Kevin Michael is listed in filings as 10% Owner at Mainz Biomed B.V.. This profile follows SEC Form 4 activity through Jan 20, 2026, including purchase activity. Recent filings connect the profile to Mainz Biomed B.V. (MYNZ). The current snapshot covers public activity from Jan 16, 2026 to Jan 20, 2026. Reported amounts are shown as $258.8B to $1.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.